Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.53 |
| ▸ | CALCR | P30988 | 11/20 | 0.53 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.52 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.52 |
| ▸ | RAMP3 | O60896 | 7/20 | 0.51 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | MC4R | P32245 | 1/20 | 0.47 |
| ▸ | NMBR | P28336 | 1/20 | 0.46 |
| ▸ | GRPR | P30550 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30862331 | 0.86 | CALCR (0.65) | F2CALCRHCRTR1HCRTR2CRHR1 | |
| SCHEMBL30827588 | 0.83 | MC4R (0.47) | F2CALCRHCRTR1HCRTR2MC4R | |
| SCHEMBL31182995 | 0.83 | CALCR (0.63) | F2CALCRHCRTR1HCRTR2RAMP3 | |
| SCHEMBL30432828 | 0.83 | CALCR (0.59) | F2CALCRHCRTR1HCRTR2CRHR1 | |
| SCHEMBL31182490 | 0.82 | CRHR1 (0.63) | F2CALCRHCRTR1HCRTR2RAMP3 | |
| SCHEMBL29903339 | 0.82 | CALCR (0.58) | F2CALCRHCRTR1HCRTR2CRHR1 | |
| SCHEMBL31182805 | 0.82 | CALCR (0.67) | F2CALCRHCRTR1HCRTR2CRHR1 | |
| SCHEMBL30272450 | 0.82 | F2 (0.46) | F2CALCRMC4R | |
| SCHEMBL30382454 | 0.82 | F2 (0.52) | F2CALCRHCRTR1HCRTR2CRHR1 | |
| SCHEMBL31031519 | 0.81 | CALCR (0.55) | F2CALCRHCRTR1HCRTR2CRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |